SCHEMBL6175022

SCHEMBL6175022

CC(c1ccnc(CO)c1)C1(C(C)c2ccnc(CO)c2)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.40
TRPV3 Q8NET8 5/20 0.39
AR P10275 4/20 0.37
KMT2A Q03164 2/20 0.34
HRH4 Q9H3N8 1/20 0.33
LMNA P02545 3/20 0.32
TP53 P04637 2/20 0.32
CYP2C9 P11712 2/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
PGR P06401 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
ALOX12 P18054 1/20 0.32
NFKB1 P19838 1/20 0.32
CYP2C19 P33261 1/20 0.32
RAB9A P51151 1/20 0.32
PDE4D Q08499 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203204 0.92 IGF1R (0.40) IGF1RTRPV3ARKMT2AHRH4
SCHEMBL6207888 0.91 IGF1R (0.40) IGF1RTRPV3ARKMT2AHRH4
SCHEMBL6176124 0.88 IGF1R (0.42) IGF1RTRPV3ARKMT2AHRH4
SCHEMBL6177630 0.86 IGF1R (0.39) IGF1RTRPV3ARKMT2AHRH4
SCHEMBL6201343 0.86 PTGS2 (0.40) IGF1RTRPV3ARKMT2AHRH4
SCHEMBL6172914 0.85 IGF1R (0.38) IGF1RTRPV3ARKMT2AHRH4
SCHEMBL6174854 0.84 POLB (0.36) ARCYP2C9CYP3A4CYP2C19
SCHEMBL6173704 0.84 IGF1R (0.45) IGF1RAR
SCHEMBL6175073 0.84 IGF1R (0.38) IGF1RTRPV3ARKMT2AHRH4
SCHEMBL6171849 0.84 IGF1R (0.39) IGF1RTRPV3ARKMT2AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed